Post-mortem serum concentrations of GFAP correlate with agony time but do not indicate a primary cerebral cause of death.

Post-mortem GFAP serum concentrations correlate with agony time and might therefore be useful for the evaluation of the severity of brain damage in prolonged death. Elevated GFAP serum levels do not indicate a primary cerebral cause of death.